Jocelyn T. Kim

University of California, Los Angeles — United States

Immunology and Microbiology · Life Sciences

15h-index1.4kcitations168works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(16), Immune Cell Function and Interaction(11), Disaster Response and Management(9), Esophageal and GI Pathology(8), SARS-CoV-2 and COVID-19 Research(5)

Publications168 total

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression
Immunity & Inflammation·2026Open Access
Modeling HIV infection, treatment, rebound, and intervention in human immune organoids
2026Open Access
NK Cells Engineered with a Chimeric Antigen Receptor Delay HIV Rebound and Reshape HIV Reservoir Composition
2026Open Access
Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns
Nature Communications·2025Open Access
Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns
Nature Communications·2025· 5 citedOpen Access
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV
Science Advances·2025Open Access
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells
Pathogens and Immunity·2024· 2 citedOpen Access
Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection
Microorganisms·2023· 12 citedOpen Access
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal
Virology·2023· 3 citedOpen Access
A humanized mouse model to study NK cell biology during HIV infection
Journal of Clinical Investigation·2022· 7 citedOpen Access
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
Stem Cell Research & Therapy·2022· 33 citedOpen Access
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Nature Communications·2022· 70 citedOpen Access
HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses
Cell Reports·2021· 35 citedOpen Access
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Journal of Visualized Experiments·2021· 11 citedOpen Access
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Journal of Visualized Experiments·2021· 4 cited
Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
Frontiers in Immunology·2021· 174 citedOpen Access
Tracking HIV Rebound following Latency Reversal Using Barcoded HIV
Cell Reports Medicine·2020· 31 citedOpen Access
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
Open Forum Infectious Diseases·2020· 13 citedOpen Access
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo
Cell Reports Medicine·2020· 61 citedOpen Access
T cell antigen discovery via trogocytosis
Nature Methods·2019· 155 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Marija Stojković(48), Thomas Junghanss(48), Charles E. Hartford(48), Asif Sharfuddin(48), Waldemar Hosch(46), Bruce A. Molitoris(45), Laura A. Cooley(24), Daniel G. Bausch(24), Jesse M. Pines(24), Andrew S. Levey(24), William G. Cioffi(24), Loretta Norton(24), Gina Soriya(24), Christopher B. Colwell(24), Anupama G. Brixey(24), Richard W. Light(24), Giorgio Della Rocca(24), Maria Gabriella Costa(24), Daniel Z. Uslan(24), Krishna K. Varadhan(24)